Neoadjuvant docetaxel and capecitabine in patients with high risk/locally advanced prostate cancer: Preliminary results of a phase II study.

被引：0
|
作者：
Friedman, JD
Vaishampayan, U
Montie, J
Shah, R
Sarkar, F
Smith, D
Hussain, M
机构：
[1] Univ Michigan, Ann Arbor, MI 48109 USA
[2] Wayne State Univ, Detroit, MI USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：438S / 438S
页数：1
相关论文
共 50 条
  • [1] Preliminary results of a phase II study of neoadjuvant treatment with docetaxel (T), doxorubicin (A) and capecitabine (X) in locally advanced or inflammatory breast cancer
    Perez-Manga, G.
    Mendez, M.
    Palomero, M. I.
    Quiben, R.
    Belon, J.
    EJC SUPPLEMENTS, 2005, 3 (02): : 133 - 133
  • [2] Preliminary results of a phase II study of neoadjuvant treatment with docetaxel (T), doxorubicin (A) and capecitabine (X) in locally advanced or inflammatory breast cancer
    Pérez-Manga, G
    Méndez, M
    Palomero, MI
    Quibén, R
    Belón, J
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S230 - S231
  • [3] A phase II trial of Neoadjuvant docetaxel and capecitabine for locally advanced breast cancer
    Lebowitz, PF
    Eng-Wong, J
    Swain, SM
    Berman, A
    Merino, MJ
    Chow, CK
    Venzon, D
    Zia, F
    Danforth, D
    Liu, E
    Zujewski, J
    CLINICAL CANCER RESEARCH, 2004, 10 (20) : 6764 - 6769
  • [4] Neoadjuvant docetaxel and capecitabine in patients with high risk prostate cancer
    Friedman, Judah
    Dunn, Rodney L.
    Wood, David
    Vaishampayan, Ulka
    Wu, Angela
    Bradley, Deborah
    Montie, James
    Sarkar, Fazlul H.
    Shah, Rajal B.
    Hussain, Maha
    JOURNAL OF UROLOGY, 2008, 179 (03): : 911 - 915
  • [5] Phase II study of docetaxel, capecitabine, and cisplatin as neoadjuvant chemotherapy for locally advanced breast cancer
    Lu, Yen-Shen
    Chen, Dar-Ren
    Tseng, Ling-Min
    Yeh, Dah-Cherng
    Chen, Shou-Tung
    Hsieh, Chia-Ming
    Wang, Hwei-Chung
    Yeh, Hsien-Tang
    Kuo, Sung-Hsin
    Huang, Chiun-Sheng
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 67 (06) : 1257 - 1263
  • [6] Phase II study of docetaxel, capecitabine, and cisplatin as neoadjuvant chemotherapy for locally advanced breast cancer
    Yen-Shen Lu
    Dar-Ren Chen
    Ling-Min Tseng
    Dah-Cherng Yeh
    Shou-Tung Chen
    Chia-Ming Hsieh
    Hwei-Chung Wang
    Hsien-Tang Yeh
    Sung-Hsin Kuo
    Chiun-Sheng Huang
    Cancer Chemotherapy and Pharmacology, 2011, 67 : 1257 - 1263
  • [7] Preliminary results of a multicenter phase II trial of neoadjuvant docetaxel, carboplatin and capecitabine for inflammatory and locally advanced breast cancer (LABC).
    Franco, SX
    Perez, A
    Frankel, C
    Tan-Chiu, E
    Schwartzberg, L
    Schwartz, M
    Krill, E
    Jakub, J
    Abramson, N
    Vogel, C
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 96S - 96S
  • [8] Preliminary results of a phase II study of neoadjuvant treatment with docetaxel (T), doxorubicin (A) and capecitabine (X) in locally advanced or inflammatory breast cancer.
    Manga, GP
    Méndez, M
    Palomero, MI
    Quibén, R
    Belón, J
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 91S - 91S
  • [9] Neoadjuvant docetaxel and capecitabine in patients (Pts) with high-risk prostate cancer (PCa): Final results of a phase II trial
    Friedman, J. D.
    Vaishampayan, U.
    Wood, D.
    Wu, A.
    Bradley, D.
    Dunn, R. L.
    Montie, J.
    Sarkar, F. H.
    Shah, R.
    Hussain, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [10] Neoadjuvant docetaxel and capecitabine in patients with high risk prostate cancer - Comment
    Morris, Michael J.
    JOURNAL OF UROLOGY, 2008, 179 (03): : 915 - 916
12345